Correlation Between Apellis Pharmaceuticals and Ascendis Pharma
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Ascendis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Ascendis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Ascendis Pharma AS, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Ascendis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Ascendis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Ascendis Pharma.
Diversification Opportunities for Apellis Pharmaceuticals and Ascendis Pharma
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Apellis and Ascendis is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Ascendis Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascendis Pharma AS and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Ascendis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascendis Pharma AS has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Ascendis Pharma go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Ascendis Pharma
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to under-perform the Ascendis Pharma. In addition to that, Apellis Pharmaceuticals is 1.34 times more volatile than Ascendis Pharma AS. It trades about -0.08 of its total potential returns per unit of risk. Ascendis Pharma AS is currently generating about 0.0 per unit of volatility. If you would invest 13,929 in Ascendis Pharma AS on November 3, 2024 and sell it today you would lose (863.00) from holding Ascendis Pharma AS or give up 6.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Ascendis Pharma AS
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Ascendis Pharma AS |
Apellis Pharmaceuticals and Ascendis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Ascendis Pharma
The main advantage of trading using opposite Apellis Pharmaceuticals and Ascendis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Ascendis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will offset losses from the drop in Ascendis Pharma's long position.| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
| Ascendis Pharma vs. Apellis Pharmaceuticals | Ascendis Pharma vs. Akero Therapeutics | Ascendis Pharma vs. Blueprint Medicines Corp | Ascendis Pharma vs. Replimune Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |